Helus Pharma Q2 EPS $(1.41) Misses $(0.64) Estimate

Benzinga · 2d ago
Helus Pharma (NASDAQ:HELP) reported quarterly losses of $(1.41) per share which missed the analyst consensus estimate of $(0.64) by 120.31 percent. This is a 1.44 percent decrease over losses of $(1.39) per share from the same period last year.